NCT06919809 2026-03-09
Effectiveness and Safety of X A-DERMâ„¢ Microsurfaced Acellular Dermal Matrix for Wound Healing After MOHS Surgery
McGuire Institute
Phase NA Completed
Clinical Trials
13 trialsNCT03886181 2025-12-08
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Terminated
NCT03889899 2025-12-02
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia.
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT04540588 2025-12-02
Retreatment With Intratumoral Diffusing Alpha Radiation Emitters
Alpha Tau Medical LTD.
Phase NA Completed
NCT03737734 2025-02-07
Alpha Radiation Emitters Device for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia (DaRT)
Alpha Tau Medical LTD.
Phase NA Active not recruiting
NCT04534127 2025-02-07
Alpha Radiation Emitters Device (DaRT) for the Treatment of Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT04068155 2024-11-22
Alpha Radiation Emitters Device for the Treatment of of Malignant Cutaneous Tumors
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT06271603 2024-02-22
ECOBASO
Damae Medical
Phase NA Unknown
NCT04936932 2022-12-08
Laser Treatment of Basal Cell Carcinoma
Sciton
Phase NA Completed
NCT03420846 2020-01-28
Efficiency of Presurgical Basal Cell Carcinoma Margin Mapping
Michelson Diagnostics Ltd.
Phase NA Terminated
NCT03621462 2018-08-08
Elucid Labs AIDAâ„¢ - Labelled Image Acquisition Protocol
Elucid Labs Inc.
Phase NA Unknown
NCT02409628 2017-09-15
EktoTherixâ„¢ Regenerative Tissue Scaffold for Repair of Surgical Excision Wounds
Neotherix Limited
Phase NA Completed
NCT01609179 2012-11-14
IPI-926 Extension Protocol for Continuation of Treatment With IPI-926
Infinity Pharmaceuticals, Inc.
Phase NA Completed